![Miguel A. de los Ríos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Miguel A. de los Ríos
Fondateur chez
Endeavor BioMedicines, Inc
Profil
Miguel A. de los Ríos was the founder of Chimeros, Inc. (founded in 2003) where he held the titles of Chairman, CEO & Chief Scientific Officer from 2009 to 2011, and RIFT biotherapeutics, Inc. (founded in 2015) where he held the title of Director, Chief Executive & Engineering Officer.
Dr. de los Ríos is also the founder of Endeavor BioMedicines, Inc. He held former positions as Vice President-Research at Sevion Therapeutics, Inc. from 2014 to 2015, Principal at Chimeros Therapeutics from 2000 to 2012, and Vice President-Research & Development at Fabrus, Inc. Dr. de los Ríos received his doctorate degree from the University of California, Santa Barbara in 2005.
Postes actifs de Miguel A. de los Ríos
| Sociétés | Poste | Début |
|---|---|---|
Endeavor BioMedicines, Inc
 Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage company that develops hedgehog inhibitor for Idiopathic pulmonary fibrosis | Fondateur | - |
Anciens postes connus de Miguel A. de los Ríos
| Sociétés | Poste | Fin |
|---|---|---|
Chimeros Therapeutics
 Chimeros Therapeutics Medical SpecialtiesHealth Technology Develops cancer therapeutic treatment services | Corporate Officer/Principal | - |
Chimeros, Inc.
 Chimeros, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer treatment | Directeur Général | 01/01/2011 |
RIFT biotherapeutics, Inc.
 RIFT biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibodies for use in oncology | Directeur Général | - |
Fabrus, Inc.
 Fabrus, Inc. BiotechnologyHealth Technology Engages in discovering, developing and engineering therapeutic antibodies | Directeur Technique/Scientifique/R&D | - |
Sevion Therapeutics, Inc.
 Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic technology for agricultural and medical applications | Directeur Technique/Scientifique/R&D | - |
Formation de Miguel A. de los Ríos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic technology for agricultural and medical applications | Commercial Services |
Chimeros, Inc.
Chimeros, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer treatment | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chimeros Therapeutics
Chimeros Therapeutics Medical SpecialtiesHealth Technology Develops cancer therapeutic treatment services | Health Technology |
Fabrus, Inc.
Fabrus, Inc. BiotechnologyHealth Technology Engages in discovering, developing and engineering therapeutic antibodies | Health Technology |
RIFT biotherapeutics, Inc.
RIFT biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibodies for use in oncology | Commercial Services |
Endeavor BioMedicines, Inc
Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage company that develops hedgehog inhibitor for Idiopathic pulmonary fibrosis | Commercial Services |
Choisissez Zonebourse 
